http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005523904-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-341 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-341 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-20 |
| filingDate | 2003-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2005-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2005523904-A |
| titleOfInvention | Antibacterial agent |
| abstract | Formula (I): [Chemical 1] [Wherein, R 1 and R 2 may be the same or different and are each selected from hydrogen, an optionally substituted C 4-30 alkyl group, and an optionally substituted C 4-30 alkenyl group. R 1 and R 2 must not both be hydrogen or R 1 and R 2 are saturated or unsaturated, substituted with the nitrogen atom to which they are attached, selected from the group consisting of Form a heterocyclic group which may contain additional heteroatoms selected from the group consisting of O, N and S, or R 1 and R 2 are the nitrogen atoms to which they are attached Together with an optionally substituted lactam moiety; X 1 is OR 3 , SR 3 , NR 3 R ′ 3 , hydrogen, halogen, CN, C (O) NR 3 R ′ 3 , C (O) OR 3, OSO 3 R 3, OPO 3 R 3 R '3, NNR R '3, SNR 3 R' 3, NHSR 3, is selected from SSR 3 and the group consisting of substituted alkyl group; X 2 is OR 4, SR 4, NR 4 R '4, hydrogen, halogen, CN, C (O ) NR 4 R ′ 4 , C (O) OR 4 , OSO 3 R 4 , OPO 3 R 4 R ′ 4 , NNR 4 R ′ 4 , SNR 4 R ′ 4 , NHSR 4 , SSR 4 and a substituted alkyl group X 3 is selected from the group; X 3 is OR 5 , SR 5 , NR 5 R ′ 5 , hydrogen, halogen, CN, C (O) NR 5 R ′ 5 , C (O) OR 5 , OSO 3 R 5 , OPO 3 R 5 R ′ 5 , NNR 5 R ′ 5 , SNR 5 R ′ 5 , NHSR 5 , SSR 5 and a substituted alkyl group are selected; X 4 is OR 6 , SR 6 , NR 6 R ′ 6 , hydrogen , halogen, CN, C (O) NR 6 R '6, C (O OR 6, OSO 3 R 6, OPO 3 R 6 R '6, NNR 6 R' 6, SNR 6 R '6, NHSR 6, SSR 6 and is selected from the group consisting of substituted alkyl group; and R 3, R' 3 , R 4 , R ′ 4 , R 5 , R ′ 5 , R 6 and R ′ 6 are the same or different and are hydrogen, optionally substituted alkyl group, optionally substituted aralkyl. Selected from the group consisting of a group, an optionally substituted aryl group, an optionally substituted acyl group and a carbohydrate moiety) Or a pharmaceutically acceptable salt thereof. |
| priorityDate | 2002-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 113.